Intuitive Surgical (NASDAQ:ISRG) Stock Price Up 1.6% – Still a Buy?

Intuitive Surgical, Inc. (NASDAQ:ISRG)’s stock price rose 1.6% on Monday . The stock traded as high as $594.34 and last traded at $592.10. Approximately 293,965 shares changed hands during trading, a decline of 84% from the average daily volume of 1,817,299 shares. The stock had previously closed at $582.98.

Analyst Ratings Changes

A number of brokerages have commented on ISRG. Wells Fargo & Company raised their price objective on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Evercore ISI raised their price target on shares of Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. Jefferies Financial Group upped their price objective on shares of Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. Robert W. Baird lifted their target price on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research note on Thursday, October 17th. Finally, JPMorgan Chase & Co. upped their price target on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Stock Down 0.3 %

The company has a 50-day moving average price of $556.91 and a 200-day moving average price of $516.98. The company has a market capitalization of $210.01 billion, a price-to-earnings ratio of 91.98, a P/E/G ratio of 5.67 and a beta of 1.39.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, CFO Jamie Samath sold 108 shares of the firm’s stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total value of $58,542.48. Following the sale, the chief financial officer now directly owns 8,757 shares in the company, valued at $4,746,819.42. This trade represents a 1.22 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Amal M. Johnson sold 4,635 shares of the business’s stock in a transaction dated Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the transaction, the director now owns 12,275 shares in the company, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 6,348 shares of company stock worth $3,587,582 in the last 90 days. 0.90% of the stock is owned by company insiders.

Institutional Trading of Intuitive Surgical

A number of hedge funds have recently modified their holdings of the company. Thurston Springer Miller Herd & Titak Inc. increased its holdings in Intuitive Surgical by 19.1% in the 3rd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 1,158 shares of the medical equipment provider’s stock valued at $569,000 after buying an additional 186 shares during the period. ORG Wealth Partners LLC acquired a new stake in shares of Intuitive Surgical during the 3rd quarter valued at about $65,000. Grove Bank & Trust increased its stake in Intuitive Surgical by 9.5% in the third quarter. Grove Bank & Trust now owns 724 shares of the medical equipment provider’s stock valued at $356,000 after acquiring an additional 63 shares during the period. CX Institutional raised its position in Intuitive Surgical by 1.5% in the third quarter. CX Institutional now owns 1,873 shares of the medical equipment provider’s stock worth $920,000 after purchasing an additional 28 shares in the last quarter. Finally, Creative Planning lifted its stake in Intuitive Surgical by 9.3% during the third quarter. Creative Planning now owns 68,881 shares of the medical equipment provider’s stock worth $33,839,000 after purchasing an additional 5,842 shares during the period. Institutional investors own 83.64% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.